An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

“The drug offers the potential for a new class of medications for the treatment of MS, the leading cause of non-traumatic disability in young adults.” While topline results of HERCULES ...

This study is believed to be the first to demonstrate a significant slowing of disability progression in patients with nrSPMS, a condition for which there are currently no US Food and Drug ...